Charles River, Labcorp and FDA Collaborate on Preclinical Abuse-Potential Methods
Charles River announced a research collaboration agreement with the FDA and Labcorp to develop screening tools to quantify and rank new drugs’ abuse potential.
Charles River announced a research collaboration agreement with the FDA and Labcorp to develop screening tools to quantify and rank new drugs’ abuse potential.